GRANISETRON B BRAUN 3 mg/3 ml, concentrate for solution for injection or infusion 5 ampoules of 3 ml
Active ingredients: Granisetron hydrochloride, Granisetron
Commercialized according to BDPMDispensing in France: Prescription only
Solution for dilution for injection or infusion5 ampoules of 3 mlintraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- GRANISETRON B BRAUN 3 mg/3 ml, solution à diluer injectable ou pour perfusion
- Pharmaceutical form
- solution injectable à diluer ou pour perfusion
- Route of administration
- intraveineuse
- Presentation description
- 5 ampoule(s) en verre de 3 ml
- Marketing authorisation holder
- B BRAUN MELSUNGEN
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 30 Apr 2024
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
69386458CIP73920089CIP133400939200897Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CHLORHYDRATE DE GRANISÉTRONsolution | — | SA |
| GRANISÉTRON BASEsolution | 1 mg · 1 ml | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.